Daré Bioscience Reports First Quarter 2019 Financial Results and Company Update
14. Mai 2019 16:00 ET
|
Dare Bioscience, Inc.
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the first quarter ended March 31, 2019...
Daré Bioscience Announces the Publication of a Pharmacokinetics Study of DARE-FRT1, a Potential Therapy for Preterm Birth and Fertility, in Drug Delivery and Translational Research
08. Mai 2019 08:00 ET
|
Dare Bioscience, Inc.
SAN DIEGO, May 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the article entitled “Pharmacokinetics and tolerability of a...
Daré Bioscience to Host First Quarter 2019 Financial Results and Company Update Conference Call and Webcast
07. Mai 2019 08:00 ET
|
Dare Bioscience, Inc.
SAN DIEGO, May 07, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30...
Dr. James Simon, Award-Winning Physician, Presents on Ovaprene® as a Promising Novel Non-Hormonal Contraceptive Method in Clinical Development
15. April 2019 08:00 ET
|
Dare Bioscience, Inc.
SAN DIEGO, April 15, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced Ovaprene’s inclusion in a presentation to physicians on the...
Daré Bioscience, Inc. Prices Underwritten Public Offering of Common Stock
09. April 2019 08:45 ET
|
Dare Bioscience, Inc.
SAN DIEGO, April 09, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), today announced the pricing of an underwritten public offering of 4,575,000 shares of its common stock at a price...
Daré Bioscience, Inc. Announces Proposed Public Offering of Common Stock
08. April 2019 16:28 ET
|
Dare Bioscience, Inc.
SAN DIEGO, April 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that it intends to offer shares of its common stock in an...
Daré Bioscience Announces Publication of Pharmacokinetics Study of DARE-HRT1, a Potential Hormone Replacement Therapy, in the Journal of Pharmaceutical Sciences
08. April 2019 08:00 ET
|
Dare Bioscience, Inc.
SAN DIEGO, April 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the article entitled “Pharmacokinetics and tolerability of a...
Daré Bioscience, Inc. Regains Listing Compliance on Nasdaq
01. April 2019 16:30 ET
|
Dare Bioscience, Inc.
SAN DIEGO, April 01, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that it received notice from The Nasdaq Stock Market LLC...
Daré Bioscience, Inc. to Host Business Update and Full Year 2018 Financial Results Conference Call and Webcast
01. April 2019 08:00 ET
|
Dare Bioscience, Inc.
SAN DIEGO, April 01, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 8:30...
World-renowned Scientist, Described as the Edison of Medicine by Forbes Magazine, Dr. Robert Langer Joins Daré Bioscience Scientific Advisory Board
29. März 2019 08:00 ET
|
Dare Bioscience, Inc.
SAN DIEGO, March 29, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, announced that Dr. Robert Langer, co-inventor of Daré‘s novel, segmented...